Read Time: 11 min read Key Takeaways Litigation status: Lawsuits involving Ozempic and other GLP-1 drugs have been grouped together in two separate multidistrict litigations (MDL), helping to expedite the legal process
Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV
What it does: Shows strong potential in animal studies for healing tendons, gut lining, nerves, and bone
The next generation of GLP-1s, which is expected to be launched next year, may demonstrate amplified effects that could include improved neuroprotection, Thiara says, but its impact would need to be validated through rigorous clinical trials, she stated
Nutritional needs of seniors